A 55-year-old woman from Hong Kong with a 2-month history of progressive right nasal obstruction and right-sided neck swelling presents to the ENT clinic. She reports no smoking or alcohol use. Flexible nasopharyngoscopy shows a friable, bleeding mass in the right nasopharynx. CT imaging reveals a 4 cm nasopharyngeal mass with erosion into the clivus and right cervical lymph nodes (largest 3 cm). Biopsy confirms squamous cell carcinoma. Which of the following is the strongest independent prognostic factor for this patient's overall survival?

Explanation

## Prognostic Factors in Nasopharyngeal Carcinoma ### Primary Prognostic Determinant **High-Yield:** TNM stage is the single strongest independent prognostic factor for overall survival in nasopharyngeal carcinoma. Advanced T-stage (skull base erosion) and nodal involvement (N1–N3) are associated with significantly worse outcomes. This patient has: - T4 disease (clivus erosion = skull base involvement) - N2 disease (3 cm ipsilateral node) - Overall Stage IVA (AJCC 8th edition) ### Staging Impact on Survival | Stage | 5-Year OS | Key Features | |-------|-----------|-------------| | Stage I | 85–90% | T1–T2, N0 | | Stage II | 75–80% | T1–T2, N1 OR T3, N0 | | Stage III | 60–70% | T1–T3, N2 OR T3, N1 | | Stage IVA | 40–50% | T4 OR N3 (any T) | | Stage IVB | <20% | Distant metastasis | **Key Point:** Nodal stage (N-stage) is particularly powerful in NPC. N3 disease (>6 cm or bilateral nodes) carries 5-year OS of ~30%, compared to N0 (~85%). ### Why Other Factors Are Secondary **EBV Seropositivity:** - Prognostic significance is **relative**, not absolute - VCA-IgA and EBNA elevation correlates with tumor burden and prognosis - However, TNM stage remains the strongest independent predictor in multivariate analysis - EBV status is useful for surveillance and recurrence detection, not primary prognostication **Smoking/Alcohol History:** - This patient denies both, yet has advanced disease - These are risk factors for development, not prognostic factors for established NPC - In endemic regions, NPC occurs in non-smokers due to EBV and genetic factors **Histologic Grade:** - Undifferentiated (WHO Type III) is most common in endemic regions - Keratinizing squamous cell (WHO Type I) is more common in non-endemic areas - Grade has less predictive power than TNM stage in NPC (unlike other head/neck cancers) ### Clinical Pearl **Warning:** Do not confuse risk factors (smoking, EBV, genetic predisposition) with prognostic factors (TNM stage, nodal involvement, distant metastasis). Prognostic factors predict outcome in established disease; risk factors predict development. ### Treatment Implications Stage IVA NPC typically requires: 1. Concurrent chemoradiotherapy (CCRT) with cisplatin 2. Induction chemotherapy (cisplatin + 5-FU) if high-risk features 3. Adjuvant chemotherapy post-CCRT **Mnemonic:** **STAMP** = **S**tage, **T**umor burden, **A**ge, **M**etastasis, **P**erformance status — all prognostic factors, but TNM is paramount.